Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_assertion type Assertion NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_head.
- NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_assertion description "[We have assessed the suitability of a number of commonly used standards for the normalization of mRNAs among a set of human breast cancer cell lines of increasing metastatic potential and have determined that 18S rRNA and beta-actin (ACTB) mRNA are both suitable for this purpose, with each having some limitations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_provenance.
- NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_assertion evidence source_evidence_literature NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_provenance.
- NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_assertion SIO_000772 15958182 NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_provenance.
- NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_assertion wasDerivedFrom befree-2016 NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_provenance.
- NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_assertion wasGeneratedBy ECO_0000203 NP499615.RA05FE22gsXs2tCNn1p9K0DUOQIhMxBaORsUdG-t3Pfvc130_provenance.